sinc
identif
kingdom
saudi
arabia
ksa
zaki
et
al
jordan
hijawi
et
al
middl
east
respiratori
syndrom
mer
becom
global
public
health
threat
typic
emerg
zoonosi
middl
east
respiratori
syndrom
coronaviru
merscov
anim
reservoir
ie
dromedari
camel
viru
caus
littl
diseas
mohd
et
al
mani
detail
extent
circul
mechan
transmiss
within
dromedari
camel
herd
factor
relat
zoonot
transmiss
differ
circul
merscov
strain
remain
unknown
viru
repeatedli
spill
dromedari
camel
human
princip
countri
arabian
peninsula
caus
signific
morbid
mortal
world
health
organ
azhar
et
al
cluster
case
commun
among
famili
member
rare
world
health
organ
howev
delay
diagnosi
hospit
sometim
led
secondari
case
among
health
care
worker
patient
share
room
famili
member
result
unprotect
direct
contact
patient
isol
humantohuman
transmiss
health
care
facil
sometim
amplifi
caus
larg
outbreak
seen
middl
east
republ
korea
signific
public
health
econom
impact
hijawi
et
al
assiri
et
al
drosten
et
al
al
hosani
et
al
ki
park
et
al
august
human
case
countri
report
world
health
organ
world
health
organ
fao
oie
tripartit
regularli
brought
togeth
affect
member
state
public
health
anim
offici
academ
discuss
known
unknown
zoonot
origin
merscov
world
health
organ
fao
fao
region
offic
eastern
mediterranean
purpos
meet
workshop
advoc
surveil
research
merscov
anim
human
share
inform
merscov
transmit
anim
anim
human
human
describ
diseas
caus
develop
polici
guidelin
detect
http
receiv
august
accept
septemb
report
anim
human
infect
prevent
human
case
cluster
two
year
sinc
last
intern
technic
consult
merscov
notabl
improv
surveil
report
human
case
multidisciplinari
research
crosssector
collabor
countri
level
public
awar
diseas
laboratori
surveil
capac
affect
countri
addit
number
countri
arabian
peninsula
africa
engag
research
activ
surveil
camel
popul
shed
light
wider
distribut
viru
investig
transmiss
pattern
rout
viral
shed
followup
previou
meet
world
health
organ
fao
fao
region
offic
eastern
mediterranean
region
offic
eastern
mediterranean
fao
oie
tripartit
held
global
technic
meet
merscov
repres
ministri
health
ministri
agricultur
subject
matter
expert
research
funder
industri
partner
septemb
geneva
switzerland
see
supplementari
inform
world
health
organ
et
al
object
review
latest
scientif
evid
merscov
enhanc
crosssector
collabor
commun
prepared
respons
activ
identifi
research
prioriti
given
advanc
knowledg
particip
largest
merscov
technic
meet
date
first
meet
attend
repres
affect
risk
countri
countri
report
human
infect
countri
evid
merscov
dromedari
camel
report
human
case
countri
risk
import
countri
without
infect
camel
close
tie
affect
countri
expatri
worker
travel
affect
countri
medic
procedur
andor
frequent
intern
travel
strong
consensu
among
stakehold
dromedari
camel
main
sourc
transmiss
human
oie
identifi
merscov
emerg
diseas
zoonot
potenti
camel
therebi
creat
expect
report
posit
camel
countri
oie
recent
publish
merscov
case
definit
oie
report
confirm
suspect
infect
camel
countri
face
risk
exampl
countri
infect
reservoir
dromedari
camel
differ
countri
dromedari
camel
show
evid
current
past
infect
fig
may
also
differ
spillov
potenti
countri
document
zoonot
transmiss
compar
without
due
sever
factor
includ
potenti
differ
husbandri
practic
cultur
social
medicin
occup
exposur
preval
underli
chronic
medic
condit
genet
factor
human
popul
merscov
viral
differ
wong
et
al
technic
risk
mitig
guidanc
protect
human
health
research
prioriti
differ
region
find
global
technic
meet
summar
surveil
need
surveil
anim
human
limit
zoonot
transmiss
routin
human
surveil
merscov
ksa
abdulaziz
et
al
throughout
middl
east
improv
sinc
identif
viru
human
signific
variat
qualiti
extent
surveil
countri
part
world
surveil
limit
sinc
known
merscov
enzoot
area
africa
asia
dromedari
camel
found
height
awar
surveil
zoonot
mer
requir
current
lack
remain
knowledg
gap
one
except
notabl
effort
identifi
potenti
merscov
infect
among
pilgrim
travel
back
middl
east
sinc
eventbas
surveil
among
pilgrim
return
hajj
umrah
religi
event
ksa
conduct
ksa
countri
send
pilgrim
mani
return
report
respiratori
symptom
merscov
infect
identifi
among
return
pilgrim
muraduzzaman
et
al
barashe
et
al
atabani
et
al
koul
et
al
annan
et
al
et
al
memish
et
al
memish
et
al
refaey
et
al
alabdallat
et
al
matthew
et
al
alqahtani
et
al
win
et
al
yavarian
et
al
kapoor
et
al
among
anim
field
survey
conduct
date
includ
sever
domest
wildlif
speci
includ
dromedari
camel
camelu
dromedariu
bactrian
camel
camelu
bactrianu
goat
bat
cattl
sheep
chicken
swine
duck
buffalo
equid
field
studi
dromedari
camel
conduct
number
countri
tabl
date
merscov
rna
merscovspecif
antibodi
identifi
dromedari
camel
number
countri
tabl
except
australia
hemida
et
al
kazakhstan
miguel
et
al
netherland
reusken
et
al
livestock
alpaca
vicugna
paco
llama
llama
paco
young
goat
rabbit
pig
shown
suscept
experiment
infect
crameri
et
al
adney
et
al
vergaraalert
et
al
despit
improv
routin
surveil
dromedari
popul
limit
lack
surveil
inform
merscov
circul
dromedari
camel
restrict
understand
transmiss
dynam
epidemiolog
dromedari
camel
popul
meet
particip
agre
surveil
integr
exist
surveil
system
particularli
atrisk
countri
similar
one
health
approach
develop
avian
influenza
exist
human
respiratori
diseas
surveil
system
set
influenzalik
ill
ili
sever
acut
respiratori
infect
sari
current
limit
abil
mitig
spillov
dromedari
camel
human
lack
clariti
mode
transmiss
dromedari
camel
human
extent
epidemiolog
merscov
circul
dromedari
camel
larg
part
africa
south
asia
zoonot
transmiss
limit
across
africa
larg
part
middl
east
part
south
asia
despit
high
seropreval
dromedari
camel
chu
et
al
tabl
fao
outlin
meet
particip
conclus
prioriti
merscov
surveil
manag
pcr
posit
dromedari
camel
coordin
outbreak
investig
commun
acquir
case
dromedari
exposur
test
anim
quarantin
entri
point
food
safeti
environment
contamin
risk
commun
awar
rais
merscov
among
anim
owner
intersector
collabor
coordin
updat
doha
declar
first
publish
fao
refhyperlink
dromedari
camel
longitudin
studi
evalu
natur
histori
shed
profil
immun
highlight
key
research
prioriti
meet
particip
agre
understand
differ
viral
strain
transmiss
dynam
includ
role
immun
acquir
infect
shed
viru
geograph
rang
spillov
event
environment
behavior
hostrel
risk
factor
zoonot
transmiss
priorit
countri
face
signific
challeng
earli
identif
diagnosi
mer
human
due
nonspecif
clinic
symptom
spectrum
ill
rang
symptom
asymptomat
infect
sever
diseas
includ
pneumonia
acut
respiratori
diseas
syndrom
organ
failur
death
case
fatal
ratio
among
report
case
world
health
organ
delay
identif
recognit
sign
symptom
compat
mer
delay
earli
isol
patient
reduc
abil
prevent
transmiss
peopl
health
care
set
notabl
emerg
depart
cardiac
care
center
renal
dialysi
unit
hijawi
et
al
assiri
et
al
drosten
et
al
al
hosani
et
al
ki
park
et
al
ahm
et
al
amer
et
al
understand
humantohuman
transmiss
health
care
set
improv
experiment
observ
studi
conduct
countri
outbreak
exampl
studi
respiratori
pathogen
yu
et
al
tran
et
al
thompson
et
al
merscov
conduct
middl
east
assiri
et
al
oboho
et
al
hunter
et
al
balkhi
et
al
republ
korea
bin
et
al
kim
et
al
kim
et
al
nam
et
al
illustr
aerosolgener
procedur
noninvas
ventil
combin
inappropri
infect
prevent
control
practic
lack
adher
standard
practic
import
role
facilit
humantohuman
transmiss
health
care
set
role
environment
contamin
evalu
number
hospit
follow
outbreak
republ
korea
collabor
experiment
studi
conduct
evalu
viabil
persist
merscov
surfac
air
bin
et
al
kim
et
al
van
doremalen
et
al
role
mild
asymptomat
case
transmiss
chain
howev
remain
unclear
omrani
et
al
memish
et
al
algethami
et
al
moon
son
alabd
et
al
warrant
target
epidemiolog
clinic
studi
conduct
among
contact
outbreak
especi
health
care
facil
countri
report
health
careassoci
outbreak
implement
varieti
strategi
improv
infect
prevent
control
reduc
humantohuman
transmiss
hospit
includ
introduct
visual
triag
system
prior
entranc
emerg
depart
restructur
emerg
depart
layout
better
triag
patient
respiratori
symptom
standard
train
retrain
infect
prevent
control
practic
facil
high
hospit
staff
turnov
audit
health
care
facil
adher
infect
prevent
control
measur
iii
product
research
develop
need
clinic
manag
diagnost
medic
intervent
r
blueprint
global
strategi
prepared
plan
allow
rapid
activ
r
epidem
pathogen
aim
fasttrack
develop
use
effect
pointofcar
diagnost
test
vaccin
medicin
use
save
live
avert
larg
scale
crise
sinc
merscov
includ
annual
r
blueprint
list
priorit
pathogen
acceler
research
develop
diagnost
vaccin
therapeut
world
health
organ
addit
merscov
specif
roadmap
product
research
develop
outlin
nonspecif
sometim
unusu
clinic
present
mer
human
make
earli
diagnosi
difficult
health
care
facil
sever
highli
specif
sensit
molecular
serolog
assay
exist
diagnosi
anim
human
corman
et
al
corman
et
al
lu
et
al
perera
et
al
reusken
et
al
et
al
song
et
al
clear
call
repres
affect
countri
develop
rapid
diagnost
test
improv
identif
isol
primari
human
case
health
care
facil
full
landscap
analysi
merscov
diagnost
publish
separ
van
kerkhov
person
commun
global
technic
meet
sever
therapeut
includ
convalesc
plasma
lopinavirritonavir
ribavirin
interferon
novel
therapi
includ
polyclon
antibodi
broadspectrum
antivir
develop
present
howev
small
case
number
make
evalu
impact
morbid
mortal
merscov
infect
difficult
arabi
et
al
arabi
et
al
aldorzi
et
al
sheahan
et
al
ko
et
al
arabi
et
al
sever
preclin
phase
iiii
studi
way
design
phase
outlin
r
blueprint
http
whoblueprintmappingtoolsurgesh
current
evalu
avail
evid
therapeut
updat
guidanc
clinic
manag
patient
process
develop
standard
clinic
trial
protocol
could
use
affect
countri
evalu
promis
therapeut
candid
identifi
target
product
profil
merscov
vaccin
includ
dromedari
camel
vaccin
reduct
zoonot
transmiss
human
vaccin
long
term
protect
high
risk
individu
work
infect
dromedari
camel
health
care
worker
human
vaccin
reactiv
use
outbreak
set
world
health
organ
current
merscovspecif
licens
human
vaccin
avail
modjarrad
et
al
world
health
organ
sever
human
vaccin
candid
coronavirus
includ
merscov
variou
stage
develop
five
gener
vaccin
technolog
platform
develop
target
merscov
spike
protein
modjarrad
et
al
okba
et
al
ministri
health
ksa
intern
vaccin
institut
ivi
continu
align
effort
develop
coronaviru
vaccin
excler
et
al
coalit
epidem
prepared
innov
cepi
includ
merscov
one
three
prioriti
pathogen
financ
human
vaccin
understand
correl
protect
reliabl
anim
model
remain
essenti
evalu
coronaviru
vaccin
candid
includ
merscov
clear
call
global
technic
meet
particip
acceler
develop
dromedari
camel
vaccin
order
evalu
potenti
reduc
spillov
transmiss
human
accept
costeffect
feasibl
dromedari
camel
vaccin
also
need
evalu
compar
intervent
strategi
human
vaccin
high
risk
group
eg
occup
exposur
merscov
endem
dromedari
camel
popul
middl
east
elsewher
multipl
intervent
strategi
includ
person
protect
measur
strateg
implement
camel
vaccin
like
need
reduc
transmiss
dromedari
camel
human
farag
et
al
antibodi
merscov
found
dromedari
camel
test
microarray
technolog
farag
et
tabl
list
priorit
research
progress
merscov
research
discuss
septemb
meet
base
enhanc
understand
viru
doha
declar
fao
undergo
revis
focu
guid
surveil
techniqu
manag
dromedari
camel
shed
viru
research
region
intersector
coordin
risk
commun
food
environment
safeti
practic
biosecur
measur
updat
includ
explicit
guidanc
import
test
quarantin
procedur
manag
shed
anim
recommend
prioriti
action
doha
declar
deliv
separ
document
valid
stakehold
affect
risk
countri
least
two
promis
camel
vaccin
candid
current
develop
evalu
field
trial
haagman
et
al
alharbi
et
al
stakehold
agre
current
fund
mechan
need
includ
riskmitig
option
target
animalhuman
interfac
prevent
zoonot
transmiss
fund
pathway
would
enabl
develop
camel
vaccin
candid
stakehold
also
agre
prior
camel
vaccin
implement
consult
camel
owner
govern
agenc
feasibl
studi
includ
explor
opportun
commerci
manufactur
incent
camel
vaccin
assess
potenti
trade
implic
would
critic
june
intern
vaccin
institut
ivi
held
joint
workshop
updat
statu
human
anim
merscov
vaccin
develop
identifi
priorit
activ
acceler
vaccin
research
develop
meet
held
seoul
korea
june
includ
expert
profession
industri
academia
intern
organ
govern
agenc
around
world
includ
coalit
epidem
prepared
innov
cepi
korean
ministri
food
drug
safeti
kmfd
korea
center
diseas
control
prevent
kcdc
global
technic
meet
serv
opportun
review
avail
evid
best
practic
control
epidem
threat
six
year
viru
first
detect
human
cover
understand
viru
abil
detect
respond
case
anim
human
popul
commun
find
work
impact
polici
decis
protect
anim
prevent
human
infect
global
technic
meet
latest
find
scientif
studi
knowledg
gain
collabor
research
surveil
share
across
anim
environment
human
sector
fao
oie
strongli
believ
effect
address
zoonos
includ
merscov
one
health
approach
prevent
detect
contain
elimin
respond
anim
public
health
risk
zoonot
high
threat
respiratori
pathogen
merscov
involv
relev
sector
public
anim
health
academ
research
commun
industri
affect
commun
acknowledg
progress
made
importantli
discuss
challeng
need
address
minim
futur
public
health
econom
impact
epidem
prone
viru
aim
articul
clear
action
plan
address
remain
unknown
foster
better
collabor
sector
subject
matter
expert
will
support
member
state
given
mark
expans
research
relat
merscov
conduct
past
two
year
fao
oie
agre
global
surveil
research
activ
must
focus
achiev
follow
major
public
health
goal
reduc
zoonot
transmiss
detect
identifi
suspect
case
earli
provid
safe
effect
treatment
reduc
human
morbid
mortal
significantli
reduc
humantohuman
transmiss
health
care
set
critic
need
research
technic
guidanc
identifi
global
technic
meet
use
inform
r
merscov
roadmap
modjarrad
et
al
broader
research
agenda
merscov
high
threat
coronavirus
research
agenda
serv
catalyst
focu
align
mobil
partner
address
outstand
knowledg
gap
relat
merscov
across
five
technic
area
viru
origin
characterist
ii
epidemiolog
transmiss
iii
clinic
manag
infect
prevent
control
iv
product
develop
implement
modjarrad
et
al
v
impact
intervent
oper
research
meet
identifi
larg
number
remain
prioriti
organ
committe
summar
main
research
need
tabl
time
devot
effort
long
term
plan
merscov
believ
focus
effort
activ
invest
address
scientif
public
health
research
question
acceler
promis
medic
intervent
strateg
activ
conduct
global
go
address
remain
public
health
unknown
improv
abil
prevent
humantohuman
transmiss
mer
case
identifi
suffici
prevent
larg
event
substanti
public
health
econom
consequ
